Printer Friendly

Articles from Chain Drug Review (September 26, 1994)

1-49 out of 49 article(s)
Title Author Type Words
ADFs continue to be among top sellers. 715
Apothecon focuses on serving retail pharmacists. 619
Artificial nail segment still growing. 851
As baby boomers grow older, cosmetics makers shift focus. 1116
Bath & shower. 968
Bath products find favor as gifts. 499
Bonne Bell, Sassaby affirm power of adolescent market. 1129
Chain drug stocks post best close of year in August. 858
Chains move toward value-added products. 496
Color-enhancing items gaining in popularity. 569
Competition in Cleveland shows industry at its best. Pinto, David 641
Consumer perception key to success in cosmetics. 702
Cosmetics organizers meet needs of time-strapped women. 1429
Dial brings back Breck girl. 470
Drug chains benefit from trend toward professional nail care. 1009
Eckerd profits surge 150% for year to date. 415
Ethex expects tremendous growth during current fiscal year. 498
Ethnic. 750
Facial. 1224
Flurry of activity marks cosmetics arena. 2260
Generics firms fight back. 685
Generics incentive plans grow. 702
Geneva becomes a leader in generics. 430
Goldline customizes programs to meet chains' needs. 449
Hand & body. (includes related articles)_ 1388
Holiday season will be critical test for fragrance category. 1278
Jean Coutu to buy 221 Brooks outlets. Stewart, Al 787
Lederle evolves into major generics manufacturer. 359
Mass retailers strengthen position in market. 477
MD puts premium on product quality. 395
Men's fragrance lines evolve. 518
Mylan continues to move ahead. 646
Neutrogena acquisition portends wave of consolidation. Sloan, Pat 982
Novopharm keeps pace with growing opportunities. 471
Personal soaps. 1358
Product intros help lift hair care sales. 1337
Purepak plans to capitalize on modified-release technology. 430
Renaissance acquires Cosmar. 410
Reputation for dependability is key element to G&W success. 433
Retailers reevaluating role of fragrances. 520
Schein strengthens position in generics market. 458
Sun care. 1388
The outlook for generics firms. Milanese, Robert 1609
Therapeutic. 620
Thrifty Payless appoints executives. 507
Total skin care: demographics and scientific breakthroughs drive category. 908
Treatment sales rise as pendulum swings back to natural nails. 661
Trends in health care bolster Taro's prospects. 549
Upscale. 727

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters